Search for: "NOVARTIS PHARMACEUTICALS CORP."
Results 221 - 240
of 367
Sorted by Relevance
|
Sort by Date
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
6 Aug 2009, 6:50 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
20 Mar 2009, 2:05 am
Novartis Pharmaceuticals Corp., 283 F.3d 254, 272 n.11 (5th Cir. 2002); Williams v. [read post]
1 Oct 2009, 2:14 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
22 Oct 2015, 8:42 am
Sorrell, of course, held that pharmaceutical promotion was First Amendment protected speech, as we discussed here. [read post]
13 May 2010, 4:58 pm
Bayer Corp. et al. [read post]
27 May 2010, 3:20 am
ICOS Corp. [read post]
9 Jan 2014, 1:37 pm
Central Garden & Pet Corp., 891 F. [read post]
1 May 2024, 1:18 pm
Novartis AG, the 2011 opinion of the U.S. [read post]
17 Feb 2010, 5:10 am
Merck, Sharp & Dohme Corp. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
2 Feb 2010, 7:28 am
Novartis Pharmaceuticals Corp., 283 F.3d 254, 270 n.10 (5th Cir. 2002) (label change); Kehm v. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
22 Dec 2010, 3:01 am
TONOPAN – no likelihood of confusion: Novartis v OHMI – Sanochemia Pharmazeutika (TOLPOSAN) (Class 46) Vanos (Fluocinonide) – US: Patent infringement complaint filed following a Paragraph IV certification: Medicis Pharmaceutical Corp. v. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote Innovation files false… [read post]
23 Jul 2008, 5:00 am
Novartis Pharmaceuticals Corp., No. 05-5350, 2008 WL 2683047 (E.D. [read post]
21 Nov 2012, 5:00 am
SmithKline Beecham Corp., 538 F. [read post]
22 Dec 2011, 11:59 am
Novartis Pharmaceuticals Corp., 793 F. [read post]
